- 9 May, 18.15-19.15 (Room Amber 3)
EMESG Business Meeting
All interested persons are cordially invited to join the meeting and plan future EMESG activities.
For more details about the congress, please check the ECCMID/ICC programme.
Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
Cornelia Blaser, Matthias Klein, Denis Grandgirard, Matthias Wittwer, Heikki Peltola, Michael Weigand, Uwe Koedel and Stephen L Leib
Ongoing EMESG research project
Meningococcal Meningitis Model in Mice
A collaborative pilot study has been set up and started to evaluate correlates of a meningococcal meningitis model in mice. Work has been performed exploiting the complementary expertise of three EMESG partners (Siena, Munich, Bern). Preliminary data are highly encouraging and joint grant applications are ongoing including application for ESCMID funding.
Ongoing EMESG medical guideline project
Guidelines on Rationale Therapeutic Management of Bacterial Meningitis
Under the leadership of Diederik van de Beek, MD, PhD, Neurologist, Academic Medical Center, a panel of experts has been formed to produce guidelines on the management of patients with bacterial meningitis. A proposal for grant support has been sent to ESCMID (Guideline Director: Erdal Akalin) for evaluation.
Histopathology in Experimental Neuroinfection
EMESG organized this ESCMID PGTW in Bern, Switzerland, 7 - 8 September 2009.
